Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia
Luming Wan, Qi Gao, Yong‐Qiang Deng, et al.
Nature Metabolism (2022) Vol. 4, Iss. 1, pp. 29-43
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Post-acute sequelae of COVID-19: A metabolic perspective
Philipp E. Scherer, John P. Kirwan, Clifford J. Rosen
eLife (2022) Vol. 11
Open Access | Times Cited: 75
Innate metabolic responses against viral infections
Clovis S. Palmer
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1245-1259
Open Access | Times Cited: 73
Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment
Pingping Feng, Xinyang Hu, Sining Zhou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis
Ester A. Barreto, Amanda Stephane Cruz dos Passos, Flávio P. Veras, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 34
Regulation of the immune system by the insulin receptor in health and disease
Priya Makhijani, Paulo José Basso, Yi Tao Chan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 29
Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress
Zhe Zhang, X. Leng, Yuan Zhai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Advances in Integrated Multi-omics Analysis for Drug-Target Identification
Peiling Du, Rui Fan, Nana Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 692-692
Open Access | Times Cited: 11
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
Rachel Wong, Emily K.Y. Lam, Carolyn T. Bramante, et al.
Current Diabetes Reports (2023) Vol. 23, Iss. 8, pp. 207-216
Open Access | Times Cited: 20
Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases
Nikolaos Perakakis, Hani Harb, Benjamin G. Hale, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 9, pp. 675-693
Open Access | Times Cited: 18
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock, Nicole Toepfner, Felix Beuschlein, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101761-101761
Open Access | Times Cited: 16
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury
Yiheng Mao, Ying Chen, Yuan Li, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113689-113689
Open Access | Times Cited: 6
Covid 19 and diabetes in children: advances and strategies
Zhaoyuan Wu, Jinling Wang, Rahim Ullah, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Insight into the function of the Golgi membrane protein GOLM1 in cholangiocytes through interactomic analysis
Meghana Nagaraj, Emmagouni Sharath Kumar Goud, Vaishali Chaurasiya, et al.
FEBS Letters (2025)
Closed Access
GOLM1 Promotes Atherogenesis by Activating Macrophage EGFR-ERK Signaling Cascade
Xiaochen Gai, Fangming Liu, Yixin Chen, et al.
Circulation Research (2025)
Closed Access
PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
Fuqiang Huang, Jing Guo, Na Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Non-human primate model of long-COVID identifies immune associates of hyperglycemia
Clovis S. Palmer, Chrysostomos Perdios, Mohamed Abdel‐Mohsen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler
Metabolism (2024) Vol. 156, pp. 155917-155917
Closed Access | Times Cited: 3
Incidence Trends of New-Onset Diabetes in Children and Adolescents Before and During the COVID-19 Pandemic: Findings From Florida
Yi Guo, Jiang Bian, Aokun Chen, et al.
Diabetes (2022) Vol. 71, Iss. 12, pp. 2702-2706
Open Access | Times Cited: 15
Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study
Jan Gojda, Kateřina Koudelková, Anna Ouřadová, et al.
Nutrition and Diabetes (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
Ningfei Ji, Mingshun Zhang, Liang Ren, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1115-1125
Open Access | Times Cited: 13
Abnormal glucose metabolism in virus associated sepsis
Peng Zhang, Shangwen Pan, Shiying Yuan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
GOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth
Meghana Nagaraj, Marcus Höring, Maria A. Ahonen, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 9, pp. 100259-100259
Open Access | Times Cited: 11
COVID-19 and diabetes — where are we now?
Rüdiger Groß, Alexander Kleger
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1611-1613
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top